Forsberg, M., Kaur, I., Pirtle, R., MD, M. D., Basar, R., Washington, D., Asfaw, T., Castro, K., Ramirez, A., Shaftoe, S., Oran, B., Lin, P., Nieto, Y., Mulanovich, V., Ariza-Heredia, E., Aljawai, Y., Chen, G., Alousi, A., Kebriaei, P., Fingrut, W., Im, J., Khouri, I., Olson, A., Mehta, R., Popat, U., Ramdial, J., Srour, S., Saini, N., Smallbone, P., Bashir, Q., Champlin, R., Shpall, E., Rezvani, K., Marin, D. (2025). Administration of off-the-shelf, expanded, most closely HLA matched, third party viral specific T cells for the therapy of adenovirus related disease in adult immunocompromised patients.. Blood. https://doi.org/10.1182/blood-2025-5951